Hedges Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17,500
Closed -$261K 112
2024
Q4
$261K Hold
17,500
0.17% 98
2024
Q3
$335K Sell
17,500
-5,000
-22% -$104K 0.22% 88
2024
Q2
$466K Hold
22,500
0.33% 78
2024
Q1
$423K Sell
22,500
-5,450
-19% -$93.5K 0.3% 75
2023
Q4
$403K Buy
27,950
+15,500
+124% +$211K 0.31% 73
2023
Q3
$216K Sell
12,450
-7,800
-39% -$163K 0.19% 98
2023
Q2
$421K Buy
20,250
+6,200
+44% +$135K 0.36% 71
2023
Q1
$330K Sell
14,050
-6,450
-31% -$173K 0.28% 79
2022
Q4
$573K Buy
20,500
+2,800
+16% +$71.6K 0.51% 52
2022
Q3
$414K Hold
17,700
0.41% 62
2022
Q2
$599K Hold
17,700
0.57% 51
2022
Q1
$618K Hold
17,700
0.48% 60
2021
Q4
$539K Buy
+17,700
New +$577K 0.42% 67

Other funds holding OGN

Hedges Asset Management's OGN Position: Q1 2025 in Review

Hedges Asset Management sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 17,500 shares — an estimated $261K sold.

Hedges Asset Management first reported a position in OGN in Q4 2021 and held it in 13 quarters. The position peaked at $618K in Q1 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Hedges Asset Management reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Hedges Asset Management sold 17,500 Organon & Co shares in Q1 2025, an estimated $261K.
  • Hedges Asset Management first reported a position in Organon & Co in Q4 2021 and held it in 13 quarters.
  • Hedges Asset Management's Organon & Co position peaked at $618K in Q1 2022.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Hedges Asset Management's 13F filing for Q1 2025, filed 24 Apr 2025.